Previous 10 |
Oakville, Ontario--(Newsfile Corp. - October 25, 2021) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular di...
Trial designed to investigate the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease Oakville, Ontario--(Newsfile Corp. - October 18, 2021) - Cardiol Therapeutics Inc . (NASDAQ: CRDL) ...
Cardiol Therapeutics Inc. (NASDAQ:CRDL) traded at a new 52-week high today of $4.85. This new high was reached on below average trading volume as 403,000 shares traded hands, while the average 30-day volume is approximately 746,000 shares. Cardiol Therapeutics Inc is a biotech company fo...
Oakville, Ontario--(Newsfile Corp. - September 16, 2021) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular diseas...
Oakville, Ontario--(Newsfile Corp. - September 10, 2021) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular diseas...
Cardiol Therapeutics Inc. (NASDAQ:CRDL) traded today at a new 52-week high of $4.29. Approximately 403,000 shares have changed hands today, as compared to an average 30-day volume of 392,000 shares. Cardiol Therapeutics Inc. (NASDAQ:CRDL) is currently priced 16.3% above its average conse...
Oakville, Ontario--(Newsfile Corp. - August 24, 2021) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular dis...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investing trends come and go, and some emerge and begin to stick for investors on and off Wall Street. From the peak of the r/WallStreetBets subreddit community earlier this year to new communities of investors discussing s...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! We’re starting off another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday. Source: f11photo/Shutterstock.com But before that, take a moment to look over som...
News, Short Squeeze, Breakout and More Instantly...
Cardiol Therapeutics Inc. Company Name:
CRDL Stock Symbol:
NASDAQ Market:
Cardiol Therapeutics Inc. Website:
Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatmen...
2024-06-26 06:30:06 ET B. Riley analyst issues BUY recommendation for CRDL on June 26, 2024 04:52AM ET. CRDL was trading at $2.12 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy recommendations . ...
Toronto, Ontario--(Newsfile Corp. - June 25, 2024) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatmen...